Dr Agarwal’s Healthcare has officially announced its IPO price band: ₹382 to ₹402 per share. The public subscription window opens on January 29 and will close on January 31, 2025.
Key IPO Details You Need to Know
- Price Band: ₹382 – ₹402 per share
- Subscription Dates: January 29 to January 31, 2025
- Anchor Investors’ Allocation: January 28, 2025
- Lot Size: 35 shares (and multiples thereof)
- P/E Ratio: 128.43x (based on FY24 earnings) at the upper price range
The IPO includes a fresh equity issuance of ₹300 crore and an offer-for-sale of 6.78 crore shares, valued at around ₹2,727.3 crore. Investors are keen to know that 50% of the shares are reserved for qualified institutional buyers (QIBs), 35% for retail investors, and 15% for non-institutional investors (NIIs).
What’s Special About Dr Agarwal’s Healthcare?
Founded in 2010, Dr. Agarwal’s Healthcare has grown into a major player in eye care services, including cataract and refractive surgeries, consultations, diagnostics, and non-surgical treatments. With a team of 737 doctors, it offers a wide range of services, including optical products and pharmaceuticals related to eye care.
The company has established a strong foothold in the healthcare sector and competes with peers like Apollo Hospitals, Max Healthcare, and Fortis Healthcare.
IPO Allotment, Refunds, and Listing Dates
- Basis of Allotment: February 3, 2025
- Refund Initiation: February 4, 2025
- Shares Credited to Demat Accounts: February 4, 2025
- Listing on BSE and NSE: February 5, 2025
Financials and Future Plans
Dr. Agarwal’s Healthcare plans to use the proceeds from this IPO to pay off debt, with around ₹195 crore earmarked for this purpose. The remaining funds will go towards inorganic acquisitions and other business needs.
Prominent investors like Temasek Holdings and TPG own stakes through their subsidiaries, which are part of the offer-for-sale portion of the IPO.
Final Thoughts on Dr. Agarwal’s Healthcare IPO
With strong demand and promising growth prospects, this IPO is expected to attract a lot of attention. Whether you’re a retail investor or a seasoned one, Dr. Agarwal’s Healthcare presents an exciting opportunity. Stay tuned for updates and mark your calendars for January 29, 2025, when the subscription window opens.
Pingback: Yes Bank Q3 Results: Net profit jumps 164.5% YoY to ₹612 crore, NII increases 10%